Monograph Four provides a general introduction to and snapshot of the
state legal authority impacting Medical Review Officer Practice and Drug-Free
Workplace program administration. Private sector/non-regulated/non-
mandated/non-DOT testing legal authority includes authority from state laws,
applicable regulations implementing those state laws, significant case law
decisions, and local ordinances or other local legal authority.
PART ONE provides a state -by-state review of state law definitions and
statutory references that impact on the role and use of a Medical Review
Officer in workplace drug testing, including an At-A-Glance Chart. Both
mandatory and voluntary drug testing laws are discussed. Voluntary laws
must be followed only if the employer seeks to take advantage of a benefit
that the statute offers, such as a reduction in an employer's workers
compensation premium if they comply with the law's requirements or
insulation from litigation under certain circumstances. However, since the
requirements of such laws can be interpreted by a court as an industry
custom and practice in a legal challenge, the legal risk involved in ignoring
such voluntary laws should be considered.
PART TWO reviews the impact of state law authority on reporting positive
and refusal to test results to State agencies. In some cases, reporting to State
agencies is the responsibility of the MRO; in others it is the responsibility of
the employer.
PART THREE addresses the issue of the review and interpretation of test
results in states where there are provisions for the use of “medical
marijuana” . While the US Departments of Transportation and Health and
Human Services have issued specific guidance and regulatory text stating that
the use of marijuana ( a Schedule I drug), even consistent with State medical
marijuana provisions, cannot be an acceptable medical explanation for a
marijuana positive test conducted under Federal authority, the MRO does
need to consider the impact of State medical marijuana provisions on the
review and interpretation of non-Federal drug test results.